Discovery in action: We find what matters and why
Our Case Studies
At MassAffinity, we have applied our platform technology across a range of challenging discovery scenarios — from undruggable targets to complex disease models. These case studies show how our platform delivers faster, more accurate results where traditional methods fall short.
Each project highlights a specific challenge, how CARMS accelerated discovery, and the impact it made.
Explore our case studies
Kir4.2 Ion Channel
Identified a new small-molecule binder for a difficult-to-study ion channel without the need for purified protein
TRPM2 Membrane Protein
Detected known and novel ligands for a traditionally undruggable membrane protein under native conditions.
CARMS Screening in Cell Lysates
Identified active compounds directly in complex cell lysates without custom assay development.